Related Experiment Video
Updated: May 9, 2025
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Association Between Vasomotor Response to Ergonovine Provocation Test and Non-Severe Coronary Artery Stenosis
Tae Shik Park1, Woo Jin Ahn2, Byoung Geol Choi3
1Division of Cardiology, VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, USA.
Background:
Coronary artery spasm (CAS) causes vasospastic angina in patients without significant coronary artery stenosis. However, there has been limited investigation regarding the CAS patterns within this population. This study aims to evaluate the incidence and patterns of CAS in patients with non-severe coronary artery stenosis using intracoronary ergonovine (ERG) provocation test.
Methods:
A total of 884 patients experiencing angina with non-severe coronary artery stenosis who underwent intracoronary ERG provocation test between January 2018 and December 2022 were enrolled. Patients were categorized into two groups, based on the severity of coronary artery stenosis: the Non-group (stenosis < 30%, n = 732), and the Mild-to-moderate group (30%-69%, n = 152). Significant CAS was defined as arterial narrowing of ≥ 70%, and vasomotor responses were observed in each group.
Results:
The baseline clinical characteristics of the Mild-to-moderate group were worse than the Non-group. They were older with higher prevalence of hypertension, diabetes mellitus, dyslipidemia, and smokers. During the ERG test, CAS was observed in 37.7% of the overall population. The Mild-to-moderate group (54.6%) showed a higher incidence than the Non-group (34.2%, p < 0.001). The Mild-to-moderate group demonstrated odds ratio of 2.31 for CAS compared to the Non-group (95% CI: 1.60-3.33, p < 0.001) even after adjustment.
Conclusions:
A considerable number of patients experiencing angina with non-severe coronary artery stenosis were found to have CAS. Moreover, CAS was observed more frequently in patients with mild to moderate coronary artery stenosis compared to those without any fixed stenosis.
Related Concept Videos
01:16Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
01:23Antihypertensive Drugs: Vasodilators
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:26Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...